Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China flag China · Delayed Price · Currency is CNY
30.24
-0.07 (-0.23%)
Apr 30, 2026, 3:04 PM CST

SHE:002864 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,230-1,1691,102823.44419.3
Cash & Short-Term Investments
1,230-1,1691,102823.44419.3
Cash Growth
5.53%-6.11%33.83%96.38%9.77%
Accounts Receivable
531.21-494.59476.42538.41446.38
Other Receivables
7.98-2.123.072.132.55
Receivables
539.19-496.71479.49540.54448.93
Inventory
117.34-95.5877.6394.6366.77
Other Current Assets
31.43-9.8618.6723.3321.45
Total Current Assets
1,918-1,7721,6781,482956.45
Property, Plant & Equipment
431.24-438.21371.7353.74275.04
Long-Term Investments
10.02-10.219.719.89-
Other Intangible Assets
49.75-51.3552.7654.956.33
Long-Term Deferred Tax Assets
12.03-4.897.2216.6320.2
Long-Term Deferred Charges
4.25-3.122.871.310.02
Other Long-Term Assets
7.03-0.712.9612.3622.13
Total Assets
2,432-2,2802,1251,9311,330
Accounts Payable
132.64-107.9291.43121.6766.01
Accrued Expenses
12.38-187.96181.38215.43176.72
Short-Term Debt
50-50100150.4687.2
Current Portion of Long-Term Debt
0.84-1-247.6213
Current Portion of Leases
--0.310.391.412.03
Current Income Taxes Payable
24.77-8.669.1114.7317.21
Current Unearned Revenue
8.07-3.685.5313.264.7
Other Current Liabilities
281.24-86.5992.57138.1170.69
Total Current Liabilities
509.95-446.11480.41902.68437.55
Long-Term Debt
100-98.5-27.3540.35
Long-Term Leases
1.51-2.332.110.331.32
Long-Term Unearned Revenue
110.18-95.991.2552.8341.4
Long-Term Deferred Tax Liabilities
-----2.35
Total Liabilities
721.64-642.84573.76983.18522.97
Common Stock
106.28-106.28106.2886.7186.67
Additional Paid-In Capital
813.9-816.64817.78259.43271.67
Retained Earnings
813.49-737.25640.06548.96463.19
Treasury Stock
-25.08--24.95-15.07-15.07-30.15
Comprehensive Income & Other
----49.62-
Total Common Equity
1,709-1,6351,549929.65791.38
Minority Interest
2.17-1.972.2117.9515.82
Shareholders' Equity
1,711-1,6371,551947.6807.21
Total Liabilities & Equity
2,432-2,2802,1251,9311,330
Total Debt
152.35-152.14102.49427.16143.9
Net Cash (Debt)
1,078-1,017999.52396.28275.41
Net Cash Growth
6.24%-1.77%152.22%43.89%-1.78%
Net Cash Per Share
10.31-9.7310.234.583.22
Filing Date Shares Outstanding
103.62101.64105.91105.1595.885.54
Total Common Shares Outstanding
103.62101.64105.91105.1585.5985.54
Working Capital
1,408-1,3251,197579.27518.89
Book Value Per Share
16.49-15.4414.7310.869.25
Tangible Book Value
1,659-1,5841,496874.75735.05
Tangible Book Value Per Share
16.01-14.9614.2310.228.59
Buildings
--398.37331.9329.36152.82
Machinery
--144.4134.72125.4160.38
Construction In Progress
--56.0529.313.85152.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.